Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aims: Initial clinical studies of pulsed field ablation (PFA) to treat atrial fibrillation (AF) indicated a >90% durability rate of pulmonary vein isolation (PVI). However, these studies were largely conducted in single centres and involved a limited number of operators. We aimed to describe the electrophysiological findings and outcomes in patients undergoing repeat ablation after an initial PF ablation for AF.

Methods And Results: In the MANIFEST-REDO study, we investigated patients who underwent repeat ablation due to clinical recurrence-AF or atrial tachycardia (AT)-following first-ever PVI with a pentaspline PFA catheter (Farawave, Boston Scientific Inc.). At 22 centres, 427 patients (age 64 ± 11 years; 37% female) were included. Of note, the recurrent arrhythmia leading to the repeat ablation was paroxysmal AF (51%), persistent AF (30%), or AT (19%). At the repeat procedure, the PV reconnection rates were 30% (left superior pulmonary vein), 28% (left inferior pulmonary vein), 33% (right superior pulmonary vein), and 32% (right inferior pulmonary vein). In 45% of patients, all PVs were durably isolated at the beginning of the repeat procedure, with the previous use of any imaging or mapping modality being univariately associated with durable PVI. After a post-redo follow-up period of 284 (90-366) days, the primary effectiveness endpoint (freedom from documented AF/AT lasting ≥30 s after 3-month blanking without class I/III antiarrhythmic drugs or symptoms) was achieved in 65% of patients, with significant differences between groups (PAF 65% vs. PersAF 56% vs. AT 76%; P = 0.04). Persistent AF as recurrent arrhythmia after the initial PFA ablation predicted AT/AF recurrence after repeat ablation [hazard ratio 1.241 (95% confidence interval 1.534-1.005); P = 0.045]. The procedural complication rate was 2.8%.

Conclusion: In repeat procedures for AF/AT performed after an index procedure with PFA for AF, PV reconnections are not uncommon. Repeat procedures can be performed safely and with an acceptable subsequent success rate.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344414PMC
http://dx.doi.org/10.1093/europace/euaf012DOI Listing

Publication Analysis

Top Keywords

pulmonary vein
20
repeat ablation
16
repeat procedures
12
repeat
9
pulsed field
8
ablation
8
field ablation
8
atrial fibrillation
8
manifest-redo study
8
recurrent arrhythmia
8

Similar Publications

Introduction: Pulmonary embolism (PE) is a life-threatening condition with well-defined management strategies; however, the presence of a clot-in-transit (CIT)-a mobile thrombus within the right heart-introduces a uniquely high-risk scenario associated with a significantly elevated mortality rate. While several therapeutic approaches are available-including anticoagulation, systemic thrombolysis, surgical embolectomy, and catheter-directed therapies-there is no established consensus on a superior treatment modality. Catheter-based mechanical thrombectomy has emerged as a promising, minimally invasive alternative that mitigates the bleeding risks of systemic thrombolysis and the invasiveness of surgery.

View Article and Find Full Text PDF

Tuberculosis (TB) is a multisystem infectious disease with both pulmonary and extrapulmonary manifestations. TB can also induce a hypercoagulable state, setting off a cascade of changes in the body, including systemic inflammation, endothelial dysfunction, and abnormalities in the coagulation and fibrinolytic pathways. Collectively, these factors significantly increase the risk of venous thromboembolism, such as deep vein thrombosis and pulmonary embolism.

View Article and Find Full Text PDF

We present a rare anatomical variation of the deep femoral vein (DFV) originating from the popliteal vein (PV) with an associated aneurysm. The DFV arose from the PV at the adductor hiatus, exhibited an aneurysm, and coursed upward through the fourth osseo-aponeurotic opening of the adductor magnus muscle to enter the anterior thigh compartment before draining into the femoral vein. This unique variation likely resulted from developmental deviations during intrauterine life.

View Article and Find Full Text PDF

BACKGROUND Central retinal vein occlusion (CRVO) is associated with cardiovascular risk factors, but hypercoagulability, endothelial dysfunction, and stasis of blood present in patients with chronic obstructive pulmonary disease (COPD) may also play a role in its pathogenesis. This report describes the case of a 70-year-old woman who presented with reduced vision in the right eye due to CRVO. CASE REPORT A 70-year-old woman with a history of smoking presented with decreased vision in the right eye.

View Article and Find Full Text PDF

Background: In 2022, the Centers for Medicare & Medicaid Services (CMS) implemented a bundled payment policy that substantially reduced reimbursement for atrial fibrillation (AF) ablation procedures, raising concerns about potential effects on utilization and procedural complexity.

Objective: To evaluate national trends in AF ablation volumes, reimbursement, and procedural complexity following the 2022 CMS reimbursement change.

Methods: Using the Medicare Physician and Other Practitioners by Geography and Service Dataset from 2016 to 2023, we identified pulmonary vein isolation (PVI) procedures using CPT 93656 and additional ablations beyond PVI using CPT 93657.

View Article and Find Full Text PDF